Navigation Links
Special Autism Issue Published by the College of Optometrists in Vision Development
Date:9/9/2009

Optometry & Vision Development, Volume 40, Number 3, 2009

AURORA, Ohio, Sept. 9 /PRNewswire-USNewswire/ -- Autism. What is its cause? How does it affect brain anatomy, electrophysiology, visual function and perception? What must we do to meet the needs of these patients? How can optometrists as health care providers be in the vanguard for screening for this spectrum of disorders?

The latest issue of Optometry & Vision Development (Vol 40 #3) tries to answer these important questions. Authors Maino, Viola and Donati investigate the many possible etiologies of Autism starting from the psycho-social belief that emotionally uninvolved parents were the cause (never true) to vaccines and the mercury they contain (doubtful) to the role genetics and environment play (most likely). Drs. Press and Richman then show us how to use preferential non-looking (gaze avoidance) vision assessment as a screening tool for young patients suspected of having Autism.

Dr. Rachel Coulter, a well known and respected expert on the many issues surrounding children with an Autism Spectrum Disorder, discusses how we can serve the special needs of those with ASD and follows up with a second article that gives us insights into the visual symptomology often noted for those with Autism. And finally Dr. Nancy Torgerson then takes us on a personal journey that she and her patients with Autism have made while participating in an optometric vision therapy program.

This issue of Optometry & Vision Development also features book reviews (Eye Power: A Cutting Edge Report on Vision Therapy and Autism Frontiers: Clinical Issues and Innovations), literature reviews, editorials and more.

About Optometry & Vision Development

Optometry & Vision Development (OVD) is a peer-reviewed open access journal indexed in the online Directory of Open Access Journals. The full text of these articles is available free from http://www.covd.org/ (click on Journal). OVD is an official publication of the College of Optometrists in Vision Development.

About COVD

The College of Optometrists in Vision Development (COVD) is an international, non-profit optometric membership organization that provides education, evaluation and board certification programs in behavioral and developmental vision care, vision therapy and visual rehabilitation. The organization is comprised of doctors of optometry, vision therapists and other vision specialists. For more information on learning-related vision problems, vision therapy and COVD, please visit www.covd.org or call 888.268.3770.

    CONTACT:  Pamela R. Happ, CAE
    COVD Executive Director
    Phone: 888.268.3770
    Email: phapp@covd.org
    Website: www.covd.org


'/>"/>
SOURCE College of Optometrists in Vision Development (COVD)
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
2. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
5. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
6. Mercedes-Benz Special Edition C350 Sport Sedan to Raise $1 Million for Saks Fifth Avenues KEY TO THE CURE
7. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
8. Uninsured community health center patients often have difficulty accessing specialty services
9. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
10. Hologic Sets Special Meeting of Stockholders to Vote on Proposed Merger with Cytyc Corporation
11. Inspiring Authors Tell Inspirational Stories: Special Writers Find Accepting Home at Lulu.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) ... per workers’ compensation claim in 2013 and 2014, according to CompScope™ Medical Benchmarks ... (WCRI) . , According to the study, medical payments per claim in California decreased ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... financial planning services from offices headquartered in Little Rock, has initiated a charity ... According to the National Foundation to End Senior Hunger, Arkansas ranks first in ...
(Date:12/8/2016)... FL (PRWEB) , ... December 08, 2016 , ... Coppin ... business owners and families in and around the Cape Coral area, is embarking on ... Chapin Food Bank of Southwest Florida. , The Harry Chapin Food Bank of Southwest ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication to ... of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of ... both sides of the Atlantic with a mechanism to comply with EU data protection ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the drug in their bodies, a researcher at the Icahn School of Medicine ... Research. , The study found that when young children are exposed to secondhand ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Agenovir Corporation, a company ... antiviral therapeutics, today announced that it appointed ... and a member of the board of directors. ... with a deep background in both founding and ... of Agenovir, co-president of Chan Zuckerberg  Biohub ...
(Date:12/8/2016)... NORWALK, Conn. , Dec. 8, 2016   Mederi Therapeutics Inc . has ... for Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). ... ... procedure performed and broadcast during the Chinese Congress of Digestive Endoscopy, by Professor Jun ... , , "We ...
(Date:12/8/2016)... ANTONIO , Dec. 8, 2016 Eli ... announced that the neoMONARCH study of abemaciclib, a cyclin-dependent ... primary endpoint of reducing expression of Ki67, a biomarker ... data from the Phase 2 trial presented during the ... Cancer Symposium (SABCS) evaluated abemaciclib, both alone or in ...
Breaking Medicine Technology: